Phillips Company has issued a voluntary recall of topical antibiotics produced by the company. The recall comes after an FDA inspection uncovered a number of manufacturing procedures which may compromise the safety of the medications made by the firm for the past 3 years. These practices were not adequate to control the quality and consistency of the product. This may have affected the safety and efficacy of the products for patient use, however, no adverse effects have been reported to date.
The drugs affected include all lots of:
These topical antibiotic products are intended for a number of uses, including the treatment of minor cuts, burns, and scrapes, as skin cleansers, and for hair growth. All of the recalled products were distributed in marked dropper bottles for topical application. These products were distributed nationwide for wholesale purposes.
The Phillips Company has notified its distributors and customers through recall letters and is arranging for the return of all recalled products. Anyone who has the product should cease its use to distribution and return unused and unexpired product to the manufacturer. Healthcare professionals and patients should report any adverse side effects experienced after use of these products to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program.
Consumers with questions are urged to contact the Philips Company by email at firstname.lastname@example.org. If a consumer has experienced issues that are possibly related to the use of any of the recalled products, they should contact their medical care provider.
Drug recalls due to faulty manufacturing can put consumers at risk of adverse reactions to the medications they need. At Bertram & Graf, L.L.C., we are dedicated to protecting consumers injured by dangerous medical products. Our Kansas City product liability attorneys are prepared to tackle your case with the highest standards of integrity and personalized attention.
Contact our offices by calling (888) 398-2277 to begin your case with a free consultation.